Patent ID: 6833142
Filing Date: 2004-12-21
Classification: A61K

Abstract:
A method of treating and/or reducing the risk of developing multiple sclerosis comprising the steps of:(i) orally administering to a subject in need thereof a first regimen once daily before bedtime in a Phase 1 period, said first regimen consisting essentially of: (a) amino acids in amount per 100 lbs of body weight consisting of: 2300 mg of L-phenylalanine, 880 mg of tyrosine, and 135 mg of tryptophan; and (b) a group of fatty acids in amount per 100 lbs of body weight consisting of: 2650 mg of lecithin. 660 mg of choline, and 440 mg of primrose oil; and (c) a group of B vitamins in amount per 100 lbs of body weight consisting of: 220 mg of niacin, 35 mcg of folio acid, and 2000 mcg of vitamin B12; and (d) a group of vitamins and minerals in amount per 100 lbs of body weight consisting of: 35 mg of beta-carotene, 1325 mg of vitamin C, 1050 mg of calcium, and 525 mg of magnesium; and (ii) thereafter orally administering to said subject a second regimen daily in a Phase 2 period, said second regimen consisting essentially of: 2100mg of lecithin, 450 mg of primrose oil, 1325 mg of choline, 2650 mg of B12, 220 mg of niacin, 700 mcg of folic acid, 35 mg of beta-carotene, 2000 mg of vitamin C, 4400 of calcium, and 2200 mg of magnesium.